NASDAQ
Adhera Therapeutics, Inc. (ATRX) has a price/fcf ratio of -1.34x as of Monday, May 25, 2026. This represents a 99.47% increase compared to its 12-month average of -252.42x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.